Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06142032 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Support Groups in the Metaverse for Ukrainian Refugees

Study acronym: METASUPUKR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 9, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Aug 2024 to Apr 2025v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2023 to Dec 20, 2023
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to test the efficacy of support groups held in the Metaverse, designed to promote mental health and well-being in Ukrainian refugees. Participants: * will be allocated to one of three conditions: (1) Metaverse support group (intervention); (2) In-Person support group (intervention); or (3) Waitlist. * will be asked to participate in 5 support group sessions, once per week, for each intervention condition. The Metaverse support groups will be compared with the In-Person support groups and with the Waitlist, to test: * the efficacy of the Metaverse condition compared to the In-Person condition. * the efficacy of the intervention conditions compared to the waitlist.
Trial Details
NCT Number NCT06142032
Lead Sponsor University of Bucharest
Conditions
(from sponsor)		 Mental Health Wellness 1, Well-Being, Psychological
Related terms Psychological Well-Being
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov